IL17A and neoplasm: We suggested that future use of this novel in vitro model might help identify the cellular source of IL-6 and IL-17 in mixed cultures of stromal + DLN cells, as well as the mechanisms implicated in the augmented production of those cytokines in the presence of tumor cells.